chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Turned away for second dose due to being on a steroid regimen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCOMPLETE COURSE OF VACCINATION (Turned away for second dose due to being on a steroid regimen) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INCOMPLETE COURSE OF VACCINATION (Turned away for second dose due to being on a steroid regimen). At the time of the report, INCOMPLETE COURSE OF VACCINATION (Turned away for second dose due to being on a steroid regimen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products known to have been used by the patient, within two weeks prior to the event, included steroids.    Treatment of the event not reported.  This report refers to a case of incomplete course of vaccination for mRNA-1273, lot # unknown  with no associated AEs.; Sender's Comments: This report refers to a case of incomplete course of vaccination for mRNA-1273, lot # unknown  with no associated AEs.
During the vaccination step of injection, a leak was noted. Since there was vaccine liquid outside of the syringe, it was likely that less than the drawn up 0.5 ml was given to the patient. Patient was notified of incomplete dose and told that she would need to be revaccinated. She verbalized understanding and was re-vaccinated with correct dose. Patient had no signs or symptoms of any adverse reaction during the 15 min post vaccination holding period.
Adverse event(s): Fever, sweating, aggressive shaking, chills, muscle ache, nausea, and persistent headache Time course: injection at 2:20p on 9/15, shaking and sweating starting at around 10:00pm, had headache/muscle ache before more intense symptoms set in. Attempted to go to work 9/16, left after 1.5 hours due to persistent headache and cold sweat.  Treatment/outcomes: fluids, hot meal (macaroni and cheese), more fluids, rest/sleep, additional hot food (assorted soups), more rest/sleep. Back to work with virtually no symptoms (mild fatigue still present) 9/17.
01/31/2023 COVID-19 symptoms cough ,fatigue, sore throat, chest congestion. I still have a lingering cough after 5 weeks.I started feeling better in the beginning of March.
Cramps, projectile vomiting. nausea , rapid heart beat , low grade fever, Horrible cramping , loose stools , rednes of face ears and neck , all cleared up in a day and a half except cramping , which lasted 2 more days
"Tingling, feeling of warmth, numbness in both feet". Paresthesia in the evening of the same day after receiving vaccine; symptoms have continued but lessened in degree. Seen by FMD on 12/02/02. No treatment and advised no more vaccines.
Information has been received from a physician concerning an approximately 60 year old patient who was vaccinated with a dose of ZOSTAVAX. Subsequently the patient developed herpes zoster of the T4 dermatome distribution of the back one week after administration of the vaccine. The patient was prescribed unspecified antiviral medication and at the time of this report was recovering. No further information was provided. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Apnea. This was the second time it occurred for more than a few seconds. The first was on 09/01/2015. I tapped him, blew my breath in his face, bought him outside, opened his shirt and rubbed his back until paramedics arrived. Diagnosis included Apnea and Esophageal reflux. He suffered from reflux until he was 7 months old. We are continually trying to find foods that won't cause it to flare up. It's difficult because he also has eczema that flares up with certain foods and lots of food allergies.
VACCINE GIVEN ON THE 10 OF JULY, CAME BACK ON JULY 20TH OF 2009 FOR A POSSIBLE REACTION TO AMOX AND DR. ALSO SUSPECTED A VACCINE REACTION. TEMPERATURE 99.0 WEIGHT 28.6 POUNDS RASH ON FACE AND CHEST. SOME AREAS HAD PIN HEAD SIZE PUSTULES. WAS GIVEN KEFLEX. CAME BACK THE 21ST OF JULY DR. CONFIRMED VACCINE REACTION TO MMR. TEMPERATURE 102.9 WEIGHT 27 POUNDS RASH SCATTERED TO BODY AND EXTREMITIES. PUSTULES ON LEGS ARE RESOLVING. TIME COURSE  WEEKS.
Patient complaints of dizziness and shortness of breathing. Provider on-site assessed the condition of the patient and was experiencing cold clammy skin. Provider recommended to give EPIPEN 0.3 and called 911
Fell in bed after vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell in bed after vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FALL (Fell in bed after vaccine). At the time of the report, FALL (Fell in bed after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-021769 (Patient Link).; Sender's Comments: Very limited information regarding this events has been provided at this time. Company assessed the events to be unlikely related to company product.
fever; chills; headache; sleepy; severe body ache; sever left arm pain after an hour of vaccine taken; severe back pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 10Mar2021 12:45 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation (at the age of 43-year-old).  Medical history included Diabetes type 2, fatty liver and asthma from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported; celecoxib (CELEXA [CELECOXIB]) taken for an unspecified indication, start and stop date were not reported; atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported; omeprazole (PROTONIX [OMEPRAZOLE]) taken for an unspecified indication, start and stop date were not reported; loratadine (ALLERTIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had no known allergies. On 10Mar2021 01:45 PM, the patient experienced sever left arm pain after an hour of vaccine taken following severe back pain. On next day 11Mar2021, the patient experienced fever, chills, headache, sleepy and severe body ache. The patient not received treatment. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
72 hrs post vax developed moderate-severe joint pain which during the next 48 hrs involved all major joint. Effusions in both knees. Treated w/maximum dose antiinflamm, non steroidal drug w/some relief.
injection site pain, right arm numbness and pain, ulnar nerve distribution nerve pain, thoracic outlet area pain, right breast pain, fever, chills, myalgia, severe headache, across chest pressure,  nausea, dizziness
Patient woke up early morning of 10/20/2023 due to pain in her left arm. Area had a rash (redness) in the middle of the upper arm on the left side. Later on she took over the counter Benadryl and 2 Ibuprofen to help with the rash and pain in the arm. She presents today 10/24/2023 with a red area around the middle of the upper arm with pain continuing today. Is better than when it first started.
This is a spontaneous report from a contactable consumer. A female patient of unspecified age had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 25Mar2021at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had experienced for Sore throat, Stuffy nose, pain, cough and Soreness at injection site. Dates for At risk for not getting the second dose of vaccine. Dates for Vaccine scheduled 22 days after the first dose. Caller unwilling to complete the report. Laboratory Investigations were not reported. Additional Context: Caller states that tomorrow she is supposed to get the second dose of the shot. Caller states that on 12Apr2021, she was in the emergency room having a sore throat, pain, and stuffy nose. Caller states that she got a strep throat test, because her grandchild had strep throat, and she reports the test was negative. Caller wants to know if it is safe to get the second dose of the vaccine tomorrow.   PSCC Communication: Caller declined to complete report. Full details not obtained and notified several times that Medical Information and/or Pfizer is unable to provide medical advice but may have resources to help answer some questions. caller abruptly disconnected before other information could be obtained.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
The pt awoke in the AM of 12/8/01 and her grandmother noted left thigh was swollen and red. She called and the pt was seen in the office. She had received Prevnar vaccine on 12/6/01 in the left thigh (lat) and it was swollen, red and warm to the touch, approx. 8cm X 12cm. She was started on Duricef X 7 days, Motrin and Benadryl for itching. Talked with mom on 12/9/01 and she stated area was not as red but about the same size. On 12/10/01, seen in office with a smaller than circled area and slight swelling. Redness was pink with no adenopathy or tissue breakdown.
whole body hurt; Uncontrollable crying; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (whole body hurt) and CRYING (Uncontrollable crying) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (whole body hurt) and CRYING (Uncontrollable crying). At the time of the report, PAIN (whole body hurt) and CRYING (Uncontrollable crying) outcome was unknown. Not Provided          This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medications were reported. Patient mother was contacted to the hospital and got the number of Pfizer. It was reported that patient received second dose of COVID-19 vaccine, patient mother and sister  had completed the two dose vaccines. Tylenol and Ibuprofen 800 was planning to give because of patient's uncontrollable crying and whole body hurt. It was reported that patient s very active and has no health problems. Caller declined to completed the report at this time because only worry about the patient. No treatment medications were reported.
A patient received a dose of Varivax following a temperature excursion; No adverse effects were reported in the patient; This spontaneous report was received from a healthcare provider and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # R019236, expiration date 04-JUL-2020, subcutaneously (dose and frequency were not reported) for prophylaxis.     The improperly stored vaccine was exposed to a temperature between 15 Fahrenheit degrees (F) and 46 F (-9 Celsius degrees and 8 Celsius degrees) with an average of 23 F; during 3 hours.  The call was because of a data logger. There were no previous temperature excursions. No product quality complaint (PQC) was involved.
violently ill each time; Initial information was received on 12-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional patient (under reference number: US-SA-SAC20211216001093). This case involves adult patient of unknown gender who experienced violently ill each time (illness) when received vaccine INFLUENZA VACCINE.  The patient never had the flu.  The patient's past medical treatment, vaccination, concomitant medication and family history were not provided.  The patient had five flu vaccines 96, 97, 98, 99 & 11 and their (medical doctor) MD advised them to avoid all vaccines.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious violently ill each time (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment for the event.  At the time of reporting, the outcome was unknown for the event (illness).  The reporter assessed the causal relationship for event (illness) with the INFLUENZA VACCINE as not reported.  There will be no information available on the batch number for this case.
Patient complained of soreness to the point she couldn't lift her arm. She did see doctor but they told her that she should put heat on it.
Fever of 101; chills; fatigue; sore throat; whole body hurts; left arm hurts bad; This is a spontaneous report from a contactable other healthcare professional (patient). A 31-years-old female patient received bnt162b2 (BNT162B2, Lot Number: EN5318), dose 2 intramuscular, administered in arm left on 08Feb2021 at 14:15 (at the age of 31-years-old) as single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took amoxicillin and experienced drug allergy and bnt162b2 (Lot number: EL9261), dose 1 intramuscular, administered in arm left on 18Jan2021 at 14:30 (at the age of 30-years-old) as single for COVID-19 immunisation. The patient did not receive any other vaccine in four weeks. On 09Feb2021, the patient experienced fever of 101, chills, fatigue, sore throat, whole body hurts and left arm hurts bad. The patient underwent lab tests and procedures which included COVID-19 test (nasal swab): negative on 08Feb2021 and body temperature: fever of 101 on 09Feb2021. The patient reported that she have not felt that sick in years. The patient did not receive any treatment for the events. The outcome of all the events was not resolved.  Follow-up attempts completed. No further information expected.
Nurse inoculates patient with second booster without realizing that she still did not meet the minimum required time of 4 months.
Client complained of dizziness after receiving 1st Pfizer Covid Vaccine (Lot EW0179 Exp. 4/28/21). Client alerted EMT  she was feeling dizzy, lightheaded, and nauseous. EMT gave client emesis bag and water. PHN  joined shortly. Upon arrival client sitting on chair, pale, mild diaphoretic and holding emesis bag. Vitals at 1250: blood pressure 100/60, pulse 79, oxygen 99%. Client stated history of anxiety with vaccines. No pertinent medical history, only medication is birth control. Vitals 1300: blood pressure 110/80, pulse 74, oxygen 99%. 1350 client stated feeling "normal". Vitals 1310: blood pressure110/80, pulse 80, oxygen 99%. Client had no complaints. Last vitals 1315: blood pressure 110/80, pulse 80, oxygen 99%. Per client no complaints, symptoms resolved. PHN advised client to follow up with primary before second dose. ER precautions given. Client left  facility with steady gait at 1320.
Crying inconsolably - no treatment given. Child was never brought: for evaluation. Crying began to improve 5/12, improving daily
Pain in upper arm since vaccine was administered. Sever cannot lift arm. Saw neurologist. Shot was given on the nerve. Prescribed Gabapentin. Unknown how long pain will last.
Massive heart attack, yelled for help to wife, 10 seconds later no pulse, called EMT, could not revive, DOA at hospital
pt recv vax 21FEB97 & pt exp inj site pain & swelling about one inch in diameter;
Burning sensation; Itching on the left arm; Rash on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation), PRURITUS (Itching on the left arm) and RASH (Rash on the left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Burning sensation), PRURITUS (Itching on the left arm) and RASH (Rash on the left arm). At the time of the report, BURNING SENSATION (Burning sensation), PRURITUS (Itching on the left arm) and RASH (Rash on the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported by the reporter No treatment medications was  provided by the reporter.
After receiving the vaccine in a patient room, I went out to waiting area. I sat down and almost immediately felt light headed, dizzy, feeling faint and a bit nauseous. I let the receptionist know. The nurse came out and asked if I had eaten and was hydrated. I did not eat much before getting the vaccine and not sure about hydration. She gave me water and crackers. After about 20 minutes, I felt OK to get up and drive home. I continued to feel a bit woozy when home and still day after. Less dizzyness today, but do have body aches, feeling a bit fluish.
exhausting; Rapid heartbeat; felt like panic attack; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Rapid heartbeat), PANIC ATTACK (felt like panic attack) and FATIGUE (exhausting) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included HYDROXYCHLOROQUINE for Rheumatoid arthritis, LEVOTHYROXINE and COLCHICINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Feb-2021, the patient experienced PALPITATIONS (Rapid heartbeat) and PANIC ATTACK (felt like panic attack). On 18-Feb-2021, the patient experienced FATIGUE (exhausting). At the time of the report, PALPITATIONS (Rapid heartbeat), PANIC ATTACK (felt like panic attack) and FATIGUE (exhausting) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Electrocardiogram: unknown (Inconclusive) she is on heart monitor and started using from 24-02-2021. No medications were given at ER.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she was feeling better but still little anxious.
Severe local reaction with 15 cm area, painful swelling. Treated with antibiotics for possible Cellulitis. No fever. Improved rapidly. Also had superficial dermatitis with non-confluent blotching, irregular lesions at periphery of zone.
PATIENT STATED SHE WAS STILL EXPERIENCING PAIN IN HER ARM 2 WEEKS AFTER RECEIVING THE VACCINATION. PAIN WAS IN THE UPPER PART OF THE ARM AND RADIATING TOWARDS HER BACK.
Woke up to swelling, itchiness and redness around injection site.  No fever.  Took Zyrtec and applied cortisone cream to arm.
This case was reported by a nurse and described the occurence of abdominal rash in a female pt who received hep B vaccine recombinant (Engerix B) plus a separate injection of hep A vaccine inactivated (Havrix). On 08Apr04, the pt received the first dose of Engerix B (lot ENG5447A6) in the right deltoid. On 08Apr04, the pt also received the first dose of Havrix (lot VHA776D6) in the left deltoid. The afternoon of the same day as the admin of Engerix B and Havrix, 08Apr04, the pt experienced abdominal rash. The event resolved approx nine days later, on 17Apr04. The nurse consideredf the abdominal rash to be related to vaccination with Engerix B and Havrix.
Headache, 3 inch red tender itchy injection site. 3 days later soreness in arm pit.
rash is extending beyond injection/ pruritic rash is extending, itch gets worse at night; wakes me up/keeps me up all night; This non-serious case was reported by a other health professional and described the occurrence of itchy rash in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 03-MAR-2023, the patient received Shingrix. In MAR-2023, an unknown time after receiving Shingrix, the patient experienced nocturnal awakening (Verbatim: wakes me up/keeps me up all night). On an unknown date, the patient experienced itchy rash (Verbatim: rash is extending beyond injection/ pruritic rash is extending, itch gets worse at night). The outcome of the itchy rash was not recovered/not resolved and the outcome of the nocturnal awakening was not reported.   It was unknown if the reporter considered the itchy rash and nocturnal awakening to be related to Shingrix.     It was unknown if the company considered the itchy rash and nocturnal awakening to be related to Shingrix.   Additional Information: GSK Receipt date: 09-Mar-2023 The patient had pruritic rash which was extending beyond injection site and gravitating dismally. The itch got worse at night and wakes her up or keeps her up all night and last 3 nights. The patient was worried if it was safe to get the second dose or not. The patient's symptoms were not treated. The reporter did not consent to follow up.